Conversely, lncRNA colon cancer associated transcript 2 (CCAT2) overexpression identified a subset of BC patients that might not benefit from cyclophosphamide, methotrexate and fluorouracil (CMF) based adjuvant chemotherapy [46]. The gene discussed is CCAT2; the disease is breast cancer.